Status:
COMPLETED
Reobtain Coronary Ostia Cannulation Beyond Transcatheter Aortic Valve Stent (RE-ACCESS)
Lead Sponsor:
University of Catania
Conditions:
Aortic Stenosis
Coronary Artery Disease
Eligibility:
All Genders
Brief Summary
With the upcoming expansion of transcatheter aortic valve replacement (TAVR) indications to younger patients, the feasibility of coronary ostia cannulation beyond different bioprosthesis stent is curr...
Detailed Description
Single-center, prospective, pilot study. Aim of this study is to assess the feasibility of coronary ostia re-engagement beyond transcatheter aortic valve (TAV) stent through a transfemoral access in 3...
Eligibility Criteria
Inclusion
- Consecutive patients with severe aortic stenosis undergoing TAVR with all commercially available devices
- Availability of preprocedural aortic root evaluation by computed tomography angiography scans
Exclusion
- TAVR in degenerated bioprostheses
- Known ostial chronic total occlusion
- Transcatheter valve not deployed in its anatomical position
- Patients with hemodynamic instability during the procedure
Key Trial Info
Start Date :
December 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04026204
Start Date
December 1 2018
End Date
February 1 2020
Last Update
September 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiology, CAST, AU Policlinico-Vittorio Emanuele
Catania, Italy, 95123